Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009.

Rota JS, Rosen JB, Doll MK, McNall RJ, McGrew M, Williams N, Lopareva EN, Barskey AE, Punsalang A Jr, Rota PA, Oleszko WR, Hickman CJ, Zimmerman CM, Bellini WJ.

Clin Vaccine Immunol. 2013 Mar;20(3):391-6. doi: 10.1128/CVI.00660-12. Epub 2013 Jan 16.

2.

Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV.

Torian LV, Forgione LA, Punsalang AE, Pirillo RE, Oleszko WR.

J Clin Virol. 2011 Dec;52 Suppl 1:S41-4. doi: 10.1016/j.jcv.2011.09.017. Epub 2011 Oct 12.

PMID:
21995935
3.

HIV type 2 in New York City, 2000-2008.

Torian LV, Eavey JJ, Punsalang AP, Pirillo RE, Forgione LA, Kent SA, Oleszko WR.

Clin Infect Dis. 2010 Dec 1;51(11):1334-42. doi: 10.1086/657117. Epub 2010 Nov 1.

PMID:
21039219
4.

Localization of a hepatitis B surface antigen determinant deduced from results of chemical modifications.

Neurath AR, Strick N, Oleszko WR.

J Virol Methods. 1981 Sep;3(2):115-25.

PMID:
6168648
5.

Passive-active immunisation against hepatitis B: immunogenicity studies in adult Americans.

Szmuness W, Stevens CE, Oleszko WR, Goodman A.

Lancet. 1981 Mar 14;1(8220 Pt 1):575-7.

PMID:
6110818
6.

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner A.

N Engl J Med. 1980 Oct 9;303(15):833-41.

PMID:
6997738
7.

An antigen detected frequently in human sera with elevated levels of alanine aminotransferase: a potential marker for non-A, non-B hepatitis.

Neurath AR, Stevens CE, Strick N, Szmuness W, Oleszko WR, Harley EJ.

J Gen Virol. 1980 Jun;48(Pt 2):285-95.

PMID:
6772739

Supplemental Content

Loading ...
Support Center